Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor, Inc.
Xencor, Inc.
City of Hope Medical Center
Novartis
AstraZeneca
Novita Pharmaceuticals, Inc.
Eli Lilly and Company
Columbia University
ADC Therapeutics S.A.
HiberCell, Inc.
Aurigene Discovery Technologies Limited
Lebanese University
MacroGenics
MacroGenics
Abramson Cancer Center at Penn Medicine
Sichuan Huiyang Life Science and Technology Corporation
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Northwestern University
Altor BioScience
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Calando Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Eisai Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
Envita Medical Center, Inc.